Reaction
Febrile Convulsion reporting signals
As of the last recalculation, Febrile Convulsion appears in 1,200 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 46.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 40 | 46.7 | 46.8 |
| Theophylline | 27 | 41.7 | 41.8 |
| Theophylline Anhydrous | 27 | 38.6 | 38.7 |
| Vigabatrin | 28 | 34.1 | 34.2 |
| Clobazam | 34 | 24.8 | 24.9 |
| Valproate Sodium | 20 | 17.1 | 17.1 |
| Levetiracetam In Sodium Chloride | 68 | 16.1 | 16.1 |
| Levetiracetam Oral | 68 | 16.1 | 16.1 |
| Levetiracetam Injection | 68 | 16.1 | 16.1 |
| Valproic Acid | 27 | 15.2 | 15.2 |
| Levocetirizine Dihydrochloride | 20 | 14.7 | 14.7 |
| Cenobamate | 7 | 14.6 | 14.6 |
| Oseltamivir Phosphate | 20 | 14.4 | 14.4 |
| Asfotase Alfa | 8 | 13.9 | 13.9 |
| Levetiracetam | 99 | 13.9 | 13.9 |
| Phenobarbital | 10 | 12.1 | 12.1 |
| Zidovudine | 9 | 11.8 | 11.8 |
| Brivaracetam | 5 | 9.7 | 9.7 |
| Lacosamide | 18 | 8.5 | 8.5 |
| Tobramycin | 10 | 7.3 | 7.3 |
| Blinatumomab | 4 | 6.7 | 6.7 |
| Dabrafenib | 8 | 6.6 | 6.6 |
| Selinexor | 3 | 6.0 | 6.0 |
| Cannabidiol | 8 | 6.0 | 6.0 |
| Carfilzomib | 9 | 5.6 | 5.6 |
| Peginterferon Beta-1A | 4 | 5.3 | 5.3 |
| Somatropin | 18 | 4.3 | 4.3 |